The reliability of the CIDI-SAM: a comprehensive substance abuse interview.

The reliability of the CIDI-SAM: a comprehensive substance abuse interview.
复制标题

CIDI-SAM 的可靠性:全面的药物滥用访谈。

DOI:
10.1111/j.1360-0443.1989.tb03060.x
复制
发表时间:
1989
期刊:
British journal of addiction
影响因子:
--
通讯作者:
Helzer,JE
Helzer,JE
中科院分区:
--
文献类型:
--
作者:
Cottler,LB;Robins,LN;Helzer,JE

文献摘要

参考文献

被引文献

相似文献

CIDI-SAM是一个完全结构化的访谈,包含DSM-III、DSM-III-R、Feighner、RDC和ICD-10对酒精、烟草和九类精神活性药物的诊断,h是应WHO/ADAMHA精神病评估工具工作组的要求设计的,以扩展CIDI的药物滥用部分。使用重测设计,在圣路易斯三家治疗机构的39名药物滥用治疗患者样本中测试了该仪器的诊断和项目可靠性。报告Kappa值及其95%置信区间和Yule Y值。DSM-III物质障碍的平均kappa值为0.84,DSM-III-R为0.82。我们报告,平均而言,优秀的Kappa值为个人酒精和药物症状。我们还从被调查者自己那里了解了为什么对具体问题的回答可能不一致。报告了这种独特的“差异访谈”的结果。
The CIDI‐SAM is a fully‐structured interview that ascertains DSM‐III, DSM‐III‐R, Feighner, RDC and ICD‐10 diagnoses for alcohol, tobacco and nine classes of psychoactive drugs, h was designed at the request of the WHO/ADAMHA Task Force on Psychiatric Assessment instruments to expand the substance abuse sections of the CIDI. Using a test‐retest design, the diagnostic and item reliabilities of this instrument were tested in a sample of 39 patients in substance abuse treatment at three St. Louis treatment facilities. Kappa values and their 95% confidence intervals, and Yule's Y values are reported. The average kappa for DSM‐III substance disorders was 0.84, for DSM‐III‐R it was 0.82. We report, on the average, excellent kappa values for individual alcohol and drug symptoms. We also ascertained from the respondent's themselves the reasons why answers to specific questions might have been discordant. The findings from this unique,‘discrepancy interview’are reported.
DOI: 10.1016/s0021-9258(17)38689-1
发表时间: 1985-11
期刊: The Journal of biological chemistry
影响因子: --
作者:
M. Greenberg;L. Greene;E. Ziff
通讯作者: M. Greenberg;L. Greene;E. Ziff
DOI: 10.1126/science.3130660
发表时间: 1988-05-20
期刊: SCIENCE
影响因子: 56.9
作者:
RAUSCHER, FJ;COHEN, DR;FRANZA, BR
通讯作者: FRANZA, BR
DOI: 10.1073/pnas.83.18.6849
发表时间: 1986-09
影响因子: 11.1
作者:
R. Ramsay;K. Ikeda;R. Rifkind;P. Marks
通讯作者: R. Ramsay;K. Ikeda;R. Rifkind;P. Marks
肌发生过程中 c-myc 的转录和转录后控制:其 mRNA 在分化细胞中保持可诱导状态,并且不会抑制分化表型
DOI: --
发表时间: 1986
影响因子: 5.3
作者:
T. Endo;B. Nadal
通讯作者: B. Nadal
DOI: --
发表时间: 1985-02
期刊: Cancer research
影响因子: 11.2
作者:
L. Grosso;H. Pitot
通讯作者: L. Grosso;H. Pitot